Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GSK3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | GSK3 |
| Key Genes/Proteins | ABL1, ACAT1, ACETYL-COA, Actin, AGING, AIF |
| Related Diseases | Aging, Als, ALS, Alzheimer, Alzheimer's disease |
| Related Pathways | Akt |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
GSK3["GSK3"]
style GSK3 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
GSK3 -->|"interacts"| MTOR([MTOR])
GSK3 -->|"target for"| Neuroinflammation["Neuroinflammation"]
GSK3 -->|"contributes to"| Huntington["Huntington"]
GSK3 -->|"target for"| Ataxia["Ataxia"]
GSK3 -->|"target for"| Inflammation["Inflammation"]
GSK3 -->|"target for"| Parkinson["Parkinson"]
GSK3 -->|"target for"| Ms["Ms"]
GSK3 -->|"target for"| Als["Als"]
GSK3 -->|"activates"| Cancer["Cancer"]
AKT([AKT]) -->|"phosphorylates"| GSK3
PARKINSON([PARKINSON]) -->|"target for"| GSK3
HIF_1_(["HIF-1Alpha"]) -->|"activates"| GSK3
MTORC1([MTORC1]) -->|"activates"| GSK3
CANCER([CANCER]) -->|"activates"| GSK3
MYC([MYC]) -->|"activates"| GSK3
MTOR -->|"activates"| GSK3
PI3K([PI3K]) -->|"activates"| GSK3
AMPK([AMPK]) -->|"activates"| GSK3| Target | Relation | Type | Str |
|---|---|---|---|
| Wnt signaling | participates_in | pathway | 0.90 |
| MAPK signaling | participates_in | pathway | 0.80 |
| oxidative stress response | participates_in | pathway | 0.80 |
| MAPK | implicated_in | gene | 0.70 |
| neurodegeneration | implicated_in | disease | 0.70 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| MTOR | interacts_with | protein | 0.70 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Alzheimer | phosphorylates | disease | 0.65 |
| Ataxia | therapeutic_target | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Als | phosphorylates | disease | 0.65 |
| Als | methylates | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Tauopathy | expressed_in | disease | 0.65 |
| ALS | regulates | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Aging | methylates | disease | 0.65 |
| Diabetes | inhibits | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Tauopathy | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Huntington | contributes_to | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Pi3K/Akt Pathway | regulates | pathway | 0.85 |
| AKT | phosphorylates | protein | 0.85 |
| PI3K/AKT | regulates | pathway | 0.85 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.82 |
| ERK | activates | gene | 0.70 |
| CDK5 | activates | gene | 0.70 |
| CDK5 | associated_with | gene | 0.70 |
| TAU | regulates | protein | 0.66 |
| AMYLOID | regulates | protein | 0.66 |
| P21 | inhibits | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| JNK | inhibits | gene | 0.60 |
| HDAC4 | inhibits | gene | 0.60 |
| CDK2 | inhibits | gene | 0.60 |
| C-JUN | inhibits | gene | 0.60 |
| HUNTINGTIN | inhibits | gene | 0.60 |
| GAIN | regulates | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| CALCOCO2 | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
| ACAT1 | associated_with | gene | 0.60 |
| OPTINEURIN | associated_with | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| SNAP29 | associated_with | gene | 0.60 |
| FIP200 | associated_with | gene | 0.60 |
| HDAC6 | associated_with | gene | 0.60 |
| UBIQUITIN | associated_with | gene | 0.60 |
| ACETYL-COA | associated_with | gene | 0.60 |
| HSPA8 | associated_with | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| CREBBP | associated_with | gene | 0.60 |
| KAT2B | associated_with | gene | 0.60 |
| P53 | associated_with | gene | 0.60 |
| LYSOSOME | regulates | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| VAMP8 | associated_with | gene | 0.60 |
| KAT8 | associated_with | gene | 0.60 |
| WIPI2 | associated_with | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| HSP70 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| KAT2A | associated_with | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| NDP52 | associated_with | gene | 0.60 |
| AGING | expressed_in | gene | 0.60 |
| DEMENTIA | expressed_in | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| PRESENILIN | expressed_in | gene | 0.60 |
| AMPK | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| MAP6-CRMPS cooperative phosphorylation by GSK3β | 0.700 | neurodegeneration | View |
| GSK3β Inhibition to Prevent α-Synuclein Phosphorylation and | 0.429 | neurodegeneration | Does RGS6 upregulation or D2 autorecepto |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GSK3 in their description or question text
No additional research found